chr16-3402200-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003450.3(ZNF174):āc.196C>Gā(p.Gln66Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000203 in 1,612,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003450.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF174 | NM_003450.3 | c.196C>G | p.Gln66Glu | missense_variant | 1/3 | ENST00000268655.5 | NP_003441.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF174 | ENST00000268655.5 | c.196C>G | p.Gln66Glu | missense_variant | 1/3 | 1 | NM_003450.3 | ENSP00000268655.4 | ||
ENSG00000285329 | ENST00000575785.2 | n.-12-2226C>G | intron_variant | 4 | ENSP00000477472.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152158Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251448Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135900
GnomAD4 exome AF: 0.000213 AC: 311AN: 1460602Hom.: 0 Cov.: 38 AF XY: 0.000180 AC XY: 131AN XY: 726584
GnomAD4 genome AF: 0.000105 AC: 16AN: 152158Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2022 | The c.196C>G (p.Q66E) alteration is located in exon 1 (coding exon 1) of the ZNF174 gene. This alteration results from a C to G substitution at nucleotide position 196, causing the glutamine (Q) at amino acid position 66 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at